πŸ‡ΊπŸ‡Έ FDA
Patent

US 8450278

MUC18 targeting peptides

granted A61KA61K38/00A61P

Quick answer

US patent 8450278 (MUC18 targeting peptides) held by The Board of Regents of the University of Texas System expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/00, A61P, A61P35/00, A61P35/02